Ive taken the punt and am now $15k lighter. The more I read and research the more my confidence grows. With the capital raising out of the way in a few weeks, the price will hopefully stabilise and rise over the next 12 months on announcements and updates.
With the federal governement estimated at covering 80% of aged care funding and with that cost steadily increasing, governments for the next 50yrs or so will be looking to reduce costs and encourage efficiency gains within the sector. Such initiatives may include updating guidelines to include automated continence assessment systems as industry best practice and increasing capital grants to encourage more efficient IT systems and practices such as SIM assessments. Mandatory automated assessments would be the holy grail for Simavita.
Governments may even, in time, become customers of Simavita and utilise SIM in the pre-assessment process to determine the level of care needed. If incontinence is one of the main reasons people are put into care, surely the government would be interested in accurately assessing the persons level of incontinence and encouraging preventative systems and practices.
Simavitas community care assessment product is due to be released soon. Its a significantly larger market and opportunity for SIM to be utilised well before people reach aged care facilities. In time, it is not hard to imagine a simplified SIM product being sold at chemists similar to the likes of Resmed's products. This would encourage and enable people to stay independent in there own homes for longer and subsequently reduce the costs on governments. The focus on preventative care will inevitably increase as the population ages and cost ramp up.
Of course the same applies to all governments across the globe with ageing populations.
Column 1
0
SVA Price at posting:
49.0¢ Sentiment: Buy Disclosure: Held